Meeting
2023 ASCO Annual Meeting
The effect of ctDNA tumor fraction (TF) on overall survival and concordance between tissue genomics and ctDNA in Lung-MAP.
Authors
Philip C. Mack
Mount Sinai Health System, New York, NY
Philip C. Mack , Mary Weber Redman , David E. Kozono , Sam Callis , Hanna Tukachinsky , Khaled A. Tolba , Joel W. Neal , Saiama Naheed Waqar , Konstantin H. Dragnev , Charu Aggarwal , Fred R. Hirsch , Jyoti D. Patel , Roy S. Herbst , Anne C. Chiang , Karen L. Reckamp , Karen Kelly , Hossein Borghaei , Jhanelle Elaine Gray , David R. Gandara
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9035)
DOI
10.1200/JCO.2023.41.16_suppl.9035
Abstract #
9035
Poster Bd #
23
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Genomic aberrations associated with overall survival (OS) in metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or placebo (PBO) plus androgen deprivation therapy (ADT) in TITAN.
First Author: Neeraj Agarwal
Poster
2019 ASCO Annual Meeting
Ductal (PDC), acinar (PAC) and neuroendocrine (PNC) carcinomas of the prostate: A comparative comprehensive genomic profiling (CGP) study.
First Author: Gennady Bratslavsky
First Author: Jie Lin
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock